AXYS Pharmaceuticals Overview
- Year Founded
-
1989
- Status
-
Acquired/Merged
- Employees
-
168
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$156M
AXYS Pharmaceuticals General Information
Description
Integrator of drug discovery technology from gene distribution through clinical development. The company focuses on small molecule therapeutics and covers a broad range of therapeutic areas including respiratory, cardiovascular, metabolic and infectious diseases, oncology and central nervous system disorders.
Contact Information
Website
www.axyspharm.comCorporate Office
- 180 Kimball Way
- South San Francisco
- South San Francisco, CA 94080
- United States
Corporate Office
- 180 Kimball Way
- South San Francisco
- South San Francisco, CA 94080
- United States
AXYS Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 16-Nov-2001 | $156M | Completed | Generating Revenue | ||
| 11. PIPE | 16-Mar-2001 | Completed | Generating Revenue | |||
| 10. PIPE | 21-Jul-2000 | Completed | Generating Revenue | |||
| 9. PIPE | 22-Feb-2000 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Open Market | 01-Jan-1998 | Completed | Startup | |||
| 7. PIPE | 01-Jan-1994 | Completed | Startup | |||
| 6. IPO | 19-Nov-1993 | Completed | Startup | |||
| 5. Later Stage VC (Series E) | 08-Apr-1993 | Completed | Startup | |||
| 4. Later Stage VC (Series D) | 11-Aug-1992 | $15.5M | $26.5M | Completed | Startup | |
| 3. Later Stage VC (Series C) | 05-Aug-1991 | $5.32M | $11M | Completed | Startup |
AXYS Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 7,600,000 | $0.010000 | 8% | $0.55 | $0.55 | 1x | $0.55 | 16.19% |
| Series A | 3,030,000 | $0.010000 | 8% | $0.5 | $0.5 | 1x | $0.5 | 6.45% |
AXYS Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
AXYS Pharmaceuticals Patents
AXYS Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-7368476-B2 | 4-{2-[3-benzofuran-2-yl-4-(2-pyrrolidin-1-ylethoxy)but-2-enoylamino]-ethoxy}-n-hydroxybenzamide hydrochloride; anticancer, bipolar disorders; inhibitors of histone deacetylase | Inactive | 07-Apr-2004 | ||
| US-20050227976-A1 | 4-{2-[3-benzofuran-2-yl-4-(2-pyrrolidin-1-ylethoxy)but-2-enoylamino]-ethoxy}-n-hydroxybenzamide hydrochloride; anticancer, bipolar disorders; inhibitors of histone deacetylase | Active | 07-Apr-2004 | ||
| US-20070088001-A1 | Silinane compounds as cysteine protease inhibitors | Inactive | 30-Jan-2004 | ||
| EP-1697355-A2 | Amidino compounds as cysteine protease inhibitors | Inactive | 23-Dec-2003 | ||
| JP-2007516295-A | Amidino compounds as cysteine protease inhibitors | Pending | 23-Dec-2003 | C07D417/14 |
AXYS Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
AXYS Pharmaceuticals Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accel | Venture Capital | Minority | ||
| Acqua Wellington | PE/Buyout | Minority | ||
| Allstate | Corporation | Minority | ||
| Bay City Capital | Venture Capital | Minority | ||
| Bessemer Venture Partners | Venture Capital | Minority |
AXYS Pharmaceuticals Acquisitions (2)
AXYS Pharmaceuticals’s most recent deal was a Merger/Acquisition with Sequana Therapeutics for . The deal was made on 09-Jan-1998.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sequana Therapeutics | 09-Jan-1998 | Merger/Acquisition | Biotechnology | ||
| Khepri Pharmaceuticals | 26-Dec-1995 | Merger/Acquisition | Biotechnology |
AXYS Pharmaceuticals FAQs
-
When was AXYS Pharmaceuticals founded?
AXYS Pharmaceuticals was founded in 1989.
-
Where is AXYS Pharmaceuticals headquartered?
AXYS Pharmaceuticals is headquartered in South San Francisco, CA.
-
What is the size of AXYS Pharmaceuticals?
AXYS Pharmaceuticals has 168 total employees.
-
What industry is AXYS Pharmaceuticals in?
AXYS Pharmaceuticals’s primary industry is Biotechnology.
-
Is AXYS Pharmaceuticals a private or public company?
AXYS Pharmaceuticals is a Private company.
-
What is the current valuation of AXYS Pharmaceuticals?
The current valuation of AXYS Pharmaceuticals is .
-
What is AXYS Pharmaceuticals’s current revenue?
The current revenue for AXYS Pharmaceuticals is .
-
How much funding has AXYS Pharmaceuticals raised over time?
AXYS Pharmaceuticals has raised $92M.
-
Who are AXYS Pharmaceuticals’s investors?
Accel, Acqua Wellington, Allstate, Bay City Capital, and Bessemer Venture Partners are 5 of 13 investors who have invested in AXYS Pharmaceuticals.
-
When was AXYS Pharmaceuticals acquired?
AXYS Pharmaceuticals was acquired on 16-Nov-2001.
-
Who acquired AXYS Pharmaceuticals?
AXYS Pharmaceuticals was acquired by Celera Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
